For instance, in bladder cancer and hepatitis B virus–related hepatocellular carcinoma, BANCR levels were notably diminished, making it a promising biomarker and therapeutic target for certain cancers (33). The gene discussed is BANCR; the disease is urinary bladder carcinoma.